跳至主要内容
临床试验/NCT05465408
NCT05465408
已完成
不适用

Addressing Non-Initiation of Recommended Adjuvant Endocrine Therapy With a Culturally Informed-Intervention

Massachusetts General Hospital11 个研究点 分布在 1 个国家目标入组 35 人2022年7月21日

概览

阶段
不适用
干预措施
Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention
疾病 / 适应症
Breast Cancer
发起方
Massachusetts General Hospital
入组人数
35
试验地点
11
主要终点
Program Feasibility
状态
已完成
最后更新
2个月前

概览

简要总结

The purpose of this study is to examine the feasibility and acceptability of a brief, nurse-led intervention to support breast cancer survivors who have delayed initiation of hormonal therapy or who have concerns about starting hormonal therapy.

详细描述

This is a single-arm pilot trial to examine the feasibility and acceptability of a patient-centered, evidence-based, culturally competent, nurse-led intervention to encourage breast cancer survivors who have not started their adjuvant endocrine therapy (AET) to initiate the medication. The research study procedures include: * screening for eligibility * two individual study intervention sessions * study assessment follow-up questionnaires This research study involves two individual sessions with a nurse practitioner, which will take place via videoconferencing, in person, or by telephone. Participants will also complete three brief questionnaire packets over the 12-week study period. It is expected that up to 35 people will take part in this research study. The investigators plan to enrich the study sample with patients from racial and/or ethnic minority groups to ensure the generalizability of the study findings.

注册库
clinicaltrials.gov
开始日期
2022年7月21日
结束日期
2024年11月20日
最后更新
2个月前
研究类型
Interventional
研究设计
Single Group
性别
Female

研究者

责任方
Principal Investigator
主要研究者

Jamie Jacobs

Principal Investigator

Massachusetts General Hospital

入排标准

入选标准

  • Age 21 or older
  • Diagnosis of early-stage (Stage I-IIIB), hormone receptor-positive breast cancer
  • Recommended to start AET at least 3 weeks prior and not currently taking AET OR recommended to start AET in the future, and reports hesitations to start AET as determined by a score of \>/= 4 (range =0-10) when asked "How hesitant are you about starting your recommended hormonal therapy? (0=Not at all hesitant and 10 = Extremely hesitant)"
  • Ability to read and respond in English or Spanish
  • Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2
  • For at least 10 participants, identify as a member of a racial or ethnic minority community per self-report

排除标准

  • Uncontrolled psychosis, active suicidal ideation, psychiatric hospitalization within the past year
  • Cognitive impairment that prohibits participation in the study
  • Undergoing primary treatment for another cancer (i.e., advanced-stage cancer)
  • Participating in a clinical trial involving AET

研究组 & 干预措施

Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention

Participants will have two (2), 60 minute, individual sessions with a nurse practitioner via videoconferencing (in person or via telephone) and complete three (3) questionnaires at the time of enrollment, 1-month post-baseline, and 3-months post-baseline.

干预措施: Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention

结局指标

主要结局

Program Feasibility

时间窗: Up to 3 months

Feasibility will be demonstrated by enrollment (\>50% of eligible and approached patients will enroll), retention (\>70% of enrolled participants will complete the two intervention sessions) and attendance (≥70% of participants completing at least one session).

Program Acceptability

时间窗: Up to 3 months

Acceptability will be demonstrated by \>75% of participants reporting average satisfaction scores greater than the mid-point of the Client Satisfaction Questionnaire. The total score range is 3-12, with higher scores indicating a better outcome.

次要结局

  • Adjuvant Endocrine Therapy (AET) Initiation(Up to 3 months)

研究点 (11)

Loading locations...

相似试验